Skip to content

Solithromycin

DRUG12 trials

Sponsors

Ando Naokatsu, Melinta Therapeutics, Inc., National Institute of Allergy and Infectious Diseases (NIAID), Imperial College London

Conditions

Bacterial InfectionBacterial InfectionsCommunity-acquired Bacterial PneumoniaGonorrhoeaMycoplasma genitalium infection Mycoplasma genitaliumMycoplasma genitalium infecton Cervicitis, Urethritis, Proctitis, Sexually transmitted infection, Mycoplasma genitalium, SolithromycinNonalcoholic SteatohepatitisPulmonary Disease, Chronic Obstructive

Phase 1

Phase 2

Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea
CompletedNCT01591447
Melinta Therapeutics, Inc.Uncomplicated Urogenital Gonorrhea
Start: 2012-05-31End: 2013-06-30Updated: 2017-03-03
Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis
CompletedNCT02510599
Melinta Therapeutics, Inc.Nonalcoholic Steatohepatitis
Start: 2015-12-31End: 2017-02-28Updated: 2017-03-21
Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
TerminatedNCT02605122
Melinta Therapeutics, Inc.Community-acquired Bacterial Pneumonia
Start: 2016-04-30End: 2018-03-21Updated: 2019-01-03
A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease
TerminatedNCT02628769
Imperial College LondonPulmonary Disease, Chronic Obstructive
Start: 2015-07-31End: 2017-01-05Updated: 2019-12-30
Placebo-controlled, double-blind, exploratory Phase 2 study of solithromycin in patients with Mycoplasma genitalium infection
RecruitingJPRN-jRCT2031250109
Ando NaokatsuMycoplasma genitalium infection Mycoplasma genitalium
Start: 2025-07-14Target: 45Updated: 2026-06-29
Exploratory Study of Solithromycin in Female Patients with Mycoplasma genitalium Infection
RecruitingJPRN-jRCTs031250792
Ando NaokatsuMycoplasma genitalium infecton Cervicitis, Urethritis, Proctitis, Sexually transmitted infection, Mycoplasma genitalium, Solithromycin
Start: 2026-03-11Target: 26Updated: 2026-06-29

Phase 3

Related Papers